Results 1,961-1,980 of 12,682 for speaker:Louise O'Reilly

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I understand that. This relates to a question I asked.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I wish to ask for clarification on that issue. Is anyone at the moment on a programme that for whatever reason has not received full endorsement where the HSE is administering the drug? The difficulty that arises for those people is who is going to administer the drug. Is anyone at the moment having the drug administered by the HSE even though it is not necessarily being fully refunded?...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: No, I am asking about patients who are separate to that and whether there is a scenario in the HSE whereby people are on a drug but the HSE is not administering it so there is no protocol that exists other than the one for the management of people at the end of clinical trials.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: The HSE would have no involvement in the administration of it? Is Mr. Flanagan certain of that?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Louise O'Reilly: I agree with the sentiments expressed. People have made huge amounts of money from this situation. I fully respect the role that the HSE plays in trying to get the best value for money. We have witnessed scenes where people protested at the gates of Leinster House. People have put pressure on us to put pressure on the HSE. The issue is cyclical, which is really unhelpful. I echo what...

Leaders' Questions (9 Nov 2017)

Louise O'Reilly: At the end of September the European Medicines Agency in London held a public hearing on the epilepsy drug sodium valproate, better known in Ireland as Epilim. The purpose of the hearing was to consider whether the warning against taking the drug while pregnant was strong enough. It followed on from a review in 2014 based on which the European Medicines Agency took the decision to...

Leaders' Questions (9 Nov 2017)

Louise O'Reilly: I thank the Tánaiste for her response. The families affected believe they have been ignored, sidelined and let down by the State. I am giving the Tánaiste an opportunity to make a statement on behalf of the Government to the effect that it will consider the issues of compensation, establishing a register for those who have taken or will take valproate and the putting in place of...

Questions on Promised Legislation (9 Nov 2017)

Louise O'Reilly: Section 5 of A Programme for a Partnership Government reads: "Resources will be set aside each year to reduce waiting lists with the funding targeted, in particular, at those most urgent cases and those whose who have been waiting longest." The latest National Treatment Purchase Fund, NTPF, figures show that overall national waiting list numbers are increasing. Some doctors predict that the...

Questions on Promised Legislation (9 Nov 2017)

Louise O'Reilly: Do.

Cannabis for Medicinal Use Regulation Bill 2016 Report: Motion [Private Members] (9 Nov 2017)

Louise O'Reilly: Níl cead ag an Teachta. Suí síos.

Cannabis for Medicinal Use Regulation Bill 2016 Report: Motion [Private Members] (9 Nov 2017)

Louise O'Reilly: I welcome our visitors in the Gallery. This is a very serious and emotive issue, on which there is a wide range of views and opinions that the House should acknowledge. Previous speakers referred to the work done by the Joint Committee on Health. I did not attend the hearings with a closed mind or with a view to being negative in any way, shape or form. At all times I approach my work with...

Cannabis for Medicinal Use Regulation Bill 2016 Report: Motion [Private Members] (9 Nov 2017)

Louise O'Reilly: That is not true.

Cannabis for Medicinal Use Regulation Bill 2016 Report: Motion [Private Members] (9 Nov 2017)

Louise O'Reilly: Deputy Barry should speak to his colleague.

Written Answers — Department of Health: Medicinal Products Data (9 Nov 2017)

Louise O'Reilly: 144. To ask the Minister for Health if a registry of the children affected by foetal anticonvulsant syndrome, also known as foetal valproate syndrome, during pregnancy will be established; and if he will make a statement on the matter. [47360/17]

Written Answers — Department of Health: Medicinal Products Data (9 Nov 2017)

Louise O'Reilly: 145. To ask the Minister for Health if a registry of the women affected by taking sodium valproate during pregnancy will be established; and if he will make a statement on the matter. [47361/17]

Written Answers — Department of Health: Medicinal Products Data (9 Nov 2017)

Louise O'Reilly: 146. To ask the Minister for Health if additional services for children affected by foetal anticonvulsant syndrome during pregnancy will be provided; and if he will make a statement on the matter. [47362/17]

Written Answers — Department of Health: Medicinal Products Data (9 Nov 2017)

Louise O'Reilly: 147. To ask the Minister for Health if a six-monthly screening process for a person exposed to sodium valproate during pregnancy will be provided in order that problems are recognised immediately and supports put in place; and if he will make a statement on the matter. [47363/17]

Written Answers — Department of Health: Medicinal Products Regulation (9 Nov 2017)

Louise O'Reilly: 148. To ask the Minister for Health the views of the HSE and his Department when their attention was drawn to the fact that pregnant women were being prescribed sodium valproate without proper provision of information on the side effects; and if he will make a statement on the matter. [47364/17]

Multi-Party Actions Bill 2017: Second Stage (14 Nov 2017)

Louise O'Reilly: I welcome the opportunity to speak on this and commend my colleagues, Deputies Ó Laoghaire and Pearse Doherty, for bringing forward this important piece of work. I am a trade unionist, as I have said in this Chamber before. For me, there is strength in numbers and unity is, indeed, strength. It is incumbent on all of us to come together and express our support not just for the Bill...

Written Answers — Department of Health: Hospital Services (14 Nov 2017)

Louise O'Reilly: 271. To ask the Minister for Health further to Parliamentary Questions Nos. 510 and 511 of 30 May 2017, his plans to address the geographical gap in heart failure services in the South-Southwest Hospital Group area; if a business case has been made for the €750,000 investment that is needed to establish heart failure services in Cork University Hospital and Kerry general hospital; the...